Welcome to our dedicated page for Vital Farms SEC filings (Ticker: VITL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vital Farms’ pasture-raised promise is simple; its SEC filings are not. Whether you’re tracking how commodity feed prices hit egg margins or verifying the scale of its 300-plus family-farm network, each report holds critical details about this ethically minded food company. Stock Titan gathers every Vital Farms SEC filing in one place and layers in AI insights so you can grasp the story behind the numbers without wading through legal jargon.
Need the Vital Farms quarterly earnings report 10-Q filing? Curious about Vital Farms insider trading Form 4 transactions? Our platform delivers real-time EDGAR updates, then distills them into plain-English takeaways—revenue by product line, feed-cost sensitivity, sustainability KPIs, and more. You’ll see Vital Farms 8-K material events explained within minutes and receive concise summaries that point you straight to the line items that move the stock.
Investors use this page to:
- Monitor Vital Farms Form 4 insider transactions real-time and spot buying by executives before material announcements.
- Compare pasture-raised segment performance across periods with AI-annotated tables from each 10-Q.
- Dive into the Vital Farms annual report 10-K simplified to understand long-term supply-chain risks.
- Review the Vital Farms proxy statement executive compensation to see how pay aligns with ESG goals.
Every document—10-K, 10-Q, 8-K, Form 4, DEF 14A—is covered, refreshed instantly, and paired with machine-generated commentary. That means Vital Farms earnings report filing analysis and “understanding Vital Farms SEC documents with AI” are no longer separate tasks. Access comprehensive coverage, expert context, and actionable clarity on one dedicated page.
Vital Farms (VITL) — insider stock transactions disclosed. A director, executive chairperson, and 10% owner reported open‑market sales made under a Rule 10b5‑1 trading plan adopted on March 14, 2025.
On 11/03/2025, the Reporting Person sold 21,408 shares at a weighted average price of $31.85, with individual trades ranging from $31.28 to $32.27, and 3,592 shares at a weighted average price of $32.35, with trades from $32.28 to $32.54. On 11/04/2025, 5,000 shares were sold at a weighted average price of $37.78, with trades from $37.01 to $38.00.
Following these transactions, the Reporting Person beneficially owned 6,417,070 shares directly. In addition, 716,000 shares are reported indirectly by a former spouse; per the disclosure, the Reporting Person has sole voting control over these shares and no pecuniary interest.
Vital Farms (VITL) reported strong Q3 fiscal 2025 results. Net revenue rose to $198.9 million from $145.0 million a year ago, driven primarily by eggs and egg-related products at $192.6 million. Gross profit increased to $75.0 million, and net income reached $16.4 million versus $7.4 million. Diluted EPS was $0.36 compared with $0.16.
For the first 39 weeks of fiscal 2025, net revenue was $545.9 million versus $440.3 million, with net income of $50.0 million versus $42.8 million. Customer concentration remained notable, with Customer A representing 24% of Q3 net revenue and 22% year-to-date. Cash and cash equivalents were $93.8 million as of September 28, 2025, alongside $51.3 million of available-for-sale U.S. Treasury Bills.
Operating cash flow was $27.9 million year-to-date, while capital expenditures totaled $44.0 million, lifting property, plant and equipment, net to $121.1 million. The company reported no borrowings on its $60.0 million JPMorgan revolving credit facility. A July 2025 tax law change reduced current tax expense, largely offset by higher deferred tax expense, with no material net effect on the quarter’s effective tax rate.
Vital Farms furnished an 8-K announcing its financial results for the fiscal quarter ended September 28, 2025. The company shared the results via a press release attached to the filing.
The press release is included as Exhibit 99.1 and is incorporated by reference. The information in this report, including Exhibit 99.1, is furnished and not deemed filed under the Exchange Act.
Vital Farms director and CEO Russell Diez-Canseco reported two sales of company common stock on
Matthew Ohayer, Executive Chairperson, Director and 10% owner of Vital Farms, Inc. (VITL), reported multiple open-market sales of common stock on 10/01/2025 completed under a Rule 10b5-1 trading plan adopted on March 14, 2025. The filing shows three sales: 600 shares at $38.17, 23,536 shares at a weighted average of $39.98, and 10,864 shares at a weighted average of $40.63, for a total of 35,000 shares sold. Following these transactions, the reporting person’s direct beneficial ownership is reported as 6,447,070 shares. The filing also discloses 716,000 shares held by a former spouse over which the reporting person has sole voting control but no pecuniary interest. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
Reena Chauhan Van Hoven, Chief People Officer of Vital Farms, Inc. (VITL), reported a routine share withholding transaction on 09/16/2025. The Form 4 shows 344 shares of Vital Farms common stock were disposed of under code F(1) at an indicated price of $47.05 per share, with the filer noting the shares were withheld to satisfy a withholding tax obligation. After this transaction the reporting person beneficially owned 10,765 shares, held directly.
The form is signed by an attorney-in-fact on behalf of the reporting person on 09/18/2025. No derivative securities or other transactions are reported on this Form 4.
Vital Farms insider Matthew Ohayer reported a sale of Common Stock on 09/04/2025. The filing shows 100,000 shares were sold at a weighted-average price of $50.96, with individual trade prices ranging from $50.75 to $51.21. After the reported disposition the filing shows Mr. Ohayer beneficially owns 6,482,070 shares directly and an additional 716,000 shares indirectly (held by his former spouse), over which he has sole voting control but no pecuniary interest. The Form 4 was signed by an attorney-in-fact on 09/08/2025 and includes an undertaking to provide trade-by-trade price details on request.
Vital Farms, Inc. (VITL) filing: insider sale notice. The document is a Form 144 reporting a proposed sale of 100,000 common shares through Morgan Stanley Smith Barney on 09/04/2025 with an aggregate market value of $5,096,010.00. The shares were originally acquired as founder stock on 01/06/2015 and paid in cash. The filer previously sold a total of 310,000 shares across multiple dates in the prior three months, generating gross proceeds shown per sale. The filing states the seller represents no undisclosed material adverse information about the issuer.
Joseph Michael Holland, identified as Chief Supply Chain Officer of Vital Farms, Inc. (VITL), reported a withholding-related disposal of company stock on 09/02/2025. The Form 4 shows 412 shares were disposed under code F(1) to satisfy withholding tax obligations at a reported price of $51.90 per share. After the transaction, the filing reports 11,451 shares beneficially owned directly by the reporting person. The form was signed by an attorney-in-fact on 09/04/2025. No derivative transactions or other securities classes are disclosed in this filing.
Matthew Ohayer, Executive Chairperson, Director and reported 10% owner of Vital Farms, Inc. (VITL), disclosed multiple sales of Common Stock. On 08/29/2025 he sold 100,000 shares at a weighted average price of $51.13, leaving 6,727,070 shares beneficially owned. On 09/02/2025 he sold 100,000 shares at $51.98 and additional lots of 20,559 and 24,441 shares at weighted prices of $51.52 and $52.39 respectively, with reported post-sale ownership levels of 6,627,070, 6,606,511 and 6,582,070 shares. An indirect holding of 716,000 shares is reported as held by a former spouse over which he has sole voting control but no pecuniary interest. Some September sales were made pursuant to a Rule 10b5-1 plan adopted March 14, 2025. The Form 4 was signed by an attorney-in-fact on 09/03/2025.